Inogen names new CFO
By HME News Staff
Updated 9:23 AM CST, Mon March 7, 2022
GOLETA, Calif. – Inogen has appointed Kristin Caltrider as executive vice president and CFO effective March 21. Caltrider joins Inogen from Quidel Corp., a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems that is listed on NASDAQ. “Kristin is a proven executive who brings deep experience in leading the financial operations of health care businesses,” said CEO Nabil Shabshab. “She has a clear track record of partnering cross functionally to successfully develop strategic plans and execute against a clear set of financial and business goals to add scale and drive profitable growth.” At Quidel, where she most recently served as vice president of finance, Caltrider oversaw global finance and accounting functions, which included all aspects of transactional and technical accounting, tax and treasury, financial planning and analysis, cash management and forecasting, and finance-related M&A activities, as well as global analytics and sales operations. She helped the company aggressively scale its manufacturing capacity and significantly expand revenue and profitability. Caltrider succeeds Mike Sergesketter, who joined the company as interim CFO in December 2021. Sergesketter will remain at the company through June 24 to facilitate a smooth transition.
Comments